LeadStory

CNBC

AbbVie reaches 3-year deal with White House to lower drug prices

CNBC · Just In
CNBC
CNBC
Just In

CNBC's Andrew Ross Sorkin reports on the latest news.

Breakdown
  • AbbVie agrees to lower drug prices for three years with White House 2s
  • Deal includes a tariff exemption for AbbVie 7s
  • AbbVie pledges $100 billion for U.S. research and development 13s
  • Similar deals were made in December with Merck, Roche, and Gilead 30s
  • Agreement is part of broader efforts to improve drug affordability 41s